PCI
Clinical trials for PCI explained in plain language.
Never miss a new study
Get alerted when new PCI trials appear
Sign up with your email to follow new studies for PCI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart surgery showdown: which procedure saves more lives in weak hearts?
Disease control Recruiting nowThis study compares two common heart procedures—bypass surgery (CABG) and stenting (PCI)—in 358 people with weak hearts (ejection fraction 40% or less) and multiple blocked arteries. The goal is to see which approach leads to better survival, fewer heart attacks or strokes, and i…
Matched conditions: PCI
Phase: NA • Sponsor: University Medical Center Groningen • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New balloon battle: which tool best cracks heart artery calcium?
Disease control Recruiting nowThis study tests two ways to break up heavy calcium buildup in heart arteries before placing a stent: a super high-pressure balloon versus a special shockwave balloon (lithotripsy). About 78 adults with severe coronary artery disease will be randomly assigned to one method. The g…
Matched conditions: PCI
Phase: NA • Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Heart stent study tests if special cameras beat standard X-Ray for reopening clogged arteries
Disease control Recruiting nowThis study compares two methods for guiding a second stent procedure in people whose drug-coated stents have re-narrowed. One method uses standard X-ray (angiography), the other adds detailed imaging from inside the artery. The goal is to see which approach leads to fewer major h…
Matched conditions: PCI
Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Diabetes drug may fight inflammation after stent procedure
Disease control Recruiting nowThis study tests whether empagliflozin, a diabetes drug, can reduce inflammation after a heart stent procedure. 100 patients with stable coronary artery disease will take either empagliflozin or a placebo for three days before their scheduled stent placement. Researchers will mea…
Matched conditions: PCI
Phase: PHASE4 • Sponsor: Hotel Dieu de France Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC